JMB-HEADER RAS-JOURNALS EIMB Pleiades Publishing

RUS

             

ENG

YearIMPACT-FACTOR
2024  1,200
2023  1,500
2022  1,200
2021  1,540
2020  1,374
2019  1,023
2018  0,932
2017  0,977
2016  0,799
2015  0,662
2014  0,740
2013  0,739
2012  0,637
2011  0,658
2010  0,654
2009  0,570
2008  0,849
2007  0,805
2006  0,330
2005  0,435
2004  0,623
2003  0,567
2002  0,641
2001  0,490
2000  0,477
1999  0,762
1998  0,785
1997  0,507
1996  0,518
1995  0,502
Vol 59(2025) N 5 p. 772-783; DOI 10.1134/S0026893325600539 Full Text

H.Yao1, N. Wang1, Z. Huan1, J. Han1, M. Zhao2*, X. Ge1,3**

OLR1 Knockdown Mitigates Traumatic-Hemorrhagic Shock- Induced Liver Injury by Inhibiting the TLR4/MYD88 Pathway and NLRP3 Inflammasome Activation

1Department of Emergency and Critical Care Medicine, Wuxi 9th People's Hospital Affiliated to Soochow University, Wuxi, Jiangsu, 214000 China
2Department of Critical Care Medicine, The First Affiliated Hospital of Harbin Medical University,Harbin, Heilongjiang, 150001 China
3Orthopedic Institution of Wuxi City, Wuxi, Jiangsu, 214000 China


*mingyan1970@126.com
**gexin2021@suda.edu.cn
Received - 2025-02-14; Revised - 2025-04-15; Accepted - 2025-04-16

Traumatic-hemorrhagic shock (T/HS) is a critical condition characterized by massive hemorrhage, hypovolemia, tissue hypoxia, and the progression to multi-organ dysfunction syndrome (MODS). To investigate the role of oxidized low-density lipoprotein receptor 1 (OLR1) in T/HS-induced liver injury, male Sprague-Dawley (SD) rats were utilized to establish a resuscitation after hemorrhagic shock (HS/R) model through controlled bloodletting and mean arterial pressure (MAP) monitoring. Immunohistochemical (IHC) staining revealed a significant upregulation of hepatic OLR1 expression following HS/R. Interfering with OLR1 significantly improved coagulation parameters, as evidenced by shortened thrombin time (TT), prothrombin time (PT), and activated partial thromboplastin time (APTT), along with reduced plasma thrombin-antithrombin (TAT) complex levels. Hematoxylin-eosin (HE) staining revealed extensive hepatocellular necrosis following HS/R, which was significantly alleviated by OLR1 knockdown. Biochemical analysis demonstrated reduced serum levels of aspartate aminotransferase (AST), alanine aminotransferase (ALT), and pro-inflammatory cytokines (IL-1β and IL-18), highlighting the protective effect of OLR1 inhibition on liver function. Mechanistic studies revealed that OLR1 mediated HS/R-induced liver injury through the activation of the toll-like receptor 4 (TLR4)/myeloid differentiation primary response 88 (MyD88) pathway and NOD-like receptor family pyrin domain containing 3 (NLRP3) inflammasome- mediated pyroptosis, both of which were suppressed by OLR1 knockdown. These findings were corroborated in vitro using BRL-3A cells. In conclusion, OLR1 mediated HS/R-induced liver injury by regulating the TLR4/MyD88/NF-κB pathway and pyroptosis. Targeting OLR1 could offer a potential therapeutic strategy to mitigate liver damage, correct coagulation abnormalities, and improve outcomes in T/HS.

OLR1, resuscitation after hemorrhagic shock, NLRP3 inflammasome, TLR4/MyD88/NF-κB pathway



JMB-FOOTER RAS-JOURNALS